← Back to Patent Explorer
US4515767A Expired / Lapsed US ⏱️ 0.0 years remaining

Radioactive metals complexed with phosphonate derivatives of dicyclopentadienebis(methylamine)

Assignee: Dow Chemical Co
•
Filing: 1983-06-20
•
Granted: 1985-05-07
•
Expires: 2003-06-20
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Complexes of radionuclides with a compound of the formula <IMAGE> wherein substituents A, B, X and Y are each independently selected from radicals including hydrogen, hydroxyalkyl (wherein the alkyl group contains 2-6 carbon atoms) phosphonic, sulfonic, methylenephosphonic, methylene-, ethylene- and propylene-sulfonic, carboxylic acid radicals (having 2-4 carbon atoms) and the alkali or alkaline earth metal, ammonia and amine salts, thereof and wherein at least one A, B, X and Y is methylenephosphonic acid or a salt thereof. Tc-99m complexes have been found useful for imaging the skeletal structure of animals.

Inventors

  • 👤 Jaime Simon
  • 👤 David A. Wilson
  • 👤 Wynn A. Volkert

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-01 23:49
CPC Classifications
A; A61; A61K; A61K51/00; A61K51/02; A61K51/04; A61K51/0474; A61K51/0487; A61K51/0404; A61K51/0406; C; C07; C07F; C07F9/00; C07F9/02; C07F9/28; C07F9/38; C07F9/3804; C07F9/3808; C07F9/3817; A61K2123/00

Claims Analysis

Total Claims: 22
Claim 1
Independent Claim 81 words
A bone seeking complex of a radioactive nuclide and a compound having the structural formula ##STR3## wherein substituents A, B, X and Y are each independently selected from radicals including hydrogen, hydroxyalkyl (wherein the alkyl group contains 2-6 carbon atoms) methylenephosphonic, methylene-, ethylene- and propylene-sulfonic, carboxylic acid radicals (having 2-4 carbon atoms) and the alkali or alkaline earth metal, ammonia and amine salts, thereof and wherein at least one A, B, X and Y is methylenephosphonic acid or a salt thereof.
Claim 2
Dependent Claim 81 words
A bone seeking complex of a radioactive nuclide and a compound having the structural formula ##STR3## wherein substituents A, B, X and Y are each independently selected from radicals including hydrogen, hydroxyalkyl (wherein the alkyl group contains 2-6 carbon atoms) methylenephosphonic, methylene-, ethylene- and propylene-sulfonic, carboxylic acid radicals (having 2-4 carbon atoms) and the alkali or alkaline earth metal, ammonia and amine salts, thereof and wherein at least one A, B, X and Y is methylenephosphonic acid or a salt thereof.
Claim 3
Dependent Claim 19 words
The complex of claim 1 wherein A, B, X and Y are each methylenephosphonic acid radicals or salts thereof.
Claim 4
Dependent Claim 12 words
The complex of claim 1 wherein the radioactive nuclide is Technetium-99 m.
Claim 5
Dependent Claim 12 words
The complex of claim 2 wherein the radioactive nuclide is Technetium-99 m.
Claim 6
Dependent Claim 16 words
A composition comprising the complex of claim 3 and a reducing agent in a saline solution.
Claim 7
Dependent Claim 16 words
A composition comprising the complex of claim 4 and a reducing agent in a saline solution.
Claim 8
Dependent Claim 13 words
The composition of claim 5 wherein the reducing agent is Sn 2+ .
Claim 9
Dependent Claim 13 words
The composition of claim 6 wherein the reducing agent is Sn 2+ .
Claim 10
Dependent Claim 15 words
The composition of claim 1 wherein the radioactive nuclide is a beta or alpha emitter.
Claim 11
Dependent Claim 15 words
The composition of claim 2 wherein the radioactive nuclide is a beta or alpha emitter.
Claim 12
Dependent Claim 10 words
The composition of claim 9 wherein the radionuclide is Re-186.
Claim 13
Dependent Claim 10 words
The composition of claim 10 wherein the radionuclide is Re-186.
Claim 14
Dependent Claim 16 words
A composition comprising the complex of claim 11 and a reducing agent in a saline solution.
Claim 15
Dependent Claim 16 words
A composition comprising the complex of claim 12 and a reducing agent in a saline solution.
Claim 16
Dependent Claim 12 words
The composition of claim 13 wherein Sn 2+ is the reducing agent.
Claim 17
Dependent Claim 12 words
The composition of claim 14 wherein Sn 2+ is the reducing agent.
Claim 18
Dependent Claim 18 words
The composition of claim 9 wherein the radionuclide is one of the lanthanide series of the periodic table.
Claim 19
Dependent Claim 18 words
The composition of claim 10 wherein the radionuclide is one of the lanthanide series of the periodic table.
Claim 20
Dependent Claim 96 words
In a process in which the skeletal system is imaged with a complex of a radionuclide the improvement which comprises employing as the complexing agent a compound having the formula ##STR4## wherein substituents A, B, X and Y are each independently selected from radicals including hydrogen, hydroxyalkyl (wherein the alkyl group contains 2-6 carbon atoms) methylenephosphonic, methylene-, ethylene- and propylene-sulfonic, carboxylic acid radicals (having 2-4 carbon atoms) and the alkali or alkaline earth metal, ammonia and amine salts, thereof and wherein at least one A, B, X and Y is methylenephosphonic acid or a salt thereof.
Claim 21
Dependent Claim 96 words
In a process in which the skeletal system is imaged with a complex of a radionuclide the improvement which comprises employing as the complexing agent a compound having the formula ##STR4## wherein substituents A, B, X and Y are each independently selected from radicals including hydrogen, hydroxyalkyl (wherein the alkyl group contains 2-6 carbon atoms) methylenephosphonic, methylene-, ethylene- and propylene-sulfonic, carboxylic acid radicals (having 2-4 carbon atoms) and the alkali or alkaline earth metal, ammonia and amine salts, thereof and wherein at least one A, B, X and Y is methylenephosphonic acid or a salt thereof.
Claim 22
Dependent Claim 20 words
The process of claim 19 wherein A, B, X and Y are each a methylenephosphonic acid or a salt thereof.

References Cited (Backward Citations)

US3989730A Cited
US3851044A Cited
US3852414A Cited
US4016249A Cited
US4082840A Cited
US3983227A Cited
US3931396A Cited
US4023625A Cited
US4075314A Cited
US4387087A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1988-05-06 1988-11-05 1989-05-07 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1992-05-06 1992-11-05 1993-05-07 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1996-05-06 1996-11-05 1997-05-07 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag